Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2017 Oct 9;10(10):CD012172.
doi: 10.1002/14651858.CD012172.pub2.

Transcutaneous electrical nerve stimulation (TENS) for fibromyalgia in adults

Mark I Johnson  1 , Leica S Claydon, G Peter Herbison, Gareth Jones, Carole A Paley
Affiliations
Meta-Analysis

Transcutaneous electrical nerve stimulation (TENS) for fibromyalgia in adults

Mark I Johnson et al. Cochrane Database Syst Rev. .

Abstract

Background: Fibromyalgia is characterised by persistent, widespread pain; sleep problems; and fatigue. Transcutaneous electrical nerve stimulation (TENS) is the delivery of pulsed electrical currents across the intact surface of the skin to stimulate peripheral nerves and is used extensively to manage painful conditions. TENS is inexpensive, safe, and can be self-administered. TENS reduces pain during movement in some people so it may be a useful adjunct to assist participation in exercise and activities of daily living. To date, there has been only one systematic review in 2012 which included TENS, amongst other treatments, for fibromyalgia, and the authors concluded that TENS was not effective.

Objectives: To assess the analgesic efficacy and adverse events of TENS alone or added to usual care (including exercise) compared with placebo (sham) TENS; no treatment; exercise alone; or other treatment including medication, electroacupuncture, warmth therapy, or hydrotherapy for fibromyalgia in adults.

Search methods: We searched the following electronic databases up to 18 January 2017: CENTRAL (CRSO); MEDLINE (Ovid); Embase (Ovid); CINAHL (EBSCO); PsycINFO (Ovid); LILACS; PEDRO; Web of Science (ISI); AMED (Ovid); and SPORTDiscus (EBSCO). We also searched three trial registries. There were no language restrictions.

Selection criteria: We included randomised controlled trials (RCTs) or quasi-randomised trials of TENS treatment for pain associated with fibromyalgia in adults. We included cross-over and parallel-group trial designs. We included studies that evaluated TENS administered using non-invasive techniques at intensities that produced perceptible TENS sensations during stimulation at either the site of pain or over nerve bundles proximal (or near) to the site of pain. We included TENS administered as a sole treatment or TENS in combination with other treatments, and TENS given as a single treatment or as a course of treatments.

Data collection and analysis: Two review authors independently determined study eligibility by assessing each record and reaching agreement by discussion. A third review author acted as arbiter. We did not anonymise the records of studies before assessment. Two review authors independently extracted data and assessed risk of bias of included studies before entering information into a 'Characteristics of included studies' table. Primary outcomes were participant-reported pain relief from baseline of 30% or greater or 50% or greater, and Patient Global Impression of Change (PGIC). We assessed the evidence using GRADE and added 'Summary of findings' tables.

Main results: We included eight studies (seven RCTs, one quasi-RCT, 315 adults (299 women), aged 18 to 75 years): six used a parallel-group design and two used a cross-over design. Sample sizes of intervention arms were five to 43 participants.Two studies, one of which was a cross-over design, compared TENS with placebo TENS (82 participants), one study compared TENS with no treatment (43 participants), and four studies compared TENS with other treatments (medication (two studies, 74 participants), electroacupuncture (one study, 44 participants), superficial warmth (one cross-over study, 32 participants), and hydrotherapy (one study, 10 participants)). Two studies compared TENS plus exercise with exercise alone (98 participants, 49 per treatment arm). None of the studies measured participant-reported pain relief of 50% or greater or PGIC. Overall, the studies were at unclear or high risk of bias, and in particular all were at high risk of bias for sample size.Only one study (14 participants) measured the primary outcome participant-reported pain relief of 30% or greater. Thirty percent achieved 30% or greater reduction in pain with TENS and exercise compared with 13% with exercise alone. One study found 10/28 participants reported pain relief of 25% or greater with TENS compared with 10/24 participants using superficial warmth (42 °C). We judged that statistical pooling was not possible because there were insufficient data and outcomes were not homogeneous.There were no data for the primary outcomes participant-reported pain relief from baseline of 50% or greater and PGIC.There was a paucity of data for secondary outcomes. One pilot cross-over study of 43 participants found that the mean (95% confidence intervals (CI)) decrease in pain intensity on movement (100-mm visual analogue scale (VAS)) during one 30-minute treatment was 11.1 mm (95% CI 5.9 to 16.3) for TENS and 2.3 mm (95% CI 2.4 to 7.7) for placebo TENS. There were no significant differences between TENS and placebo for pain at rest. One parallel group study of 39 participants found that mean ± standard deviation (SD) pain intensity (100-mm VAS) decreased from 85 ± 20 mm at baseline to 43 ± 20 mm after one week of dual-site TENS; decreased from 85 ± 10 mm at baseline to 60 ± 10 mm after single-site TENS; and decreased from 82 ± 20 mm at baseline to 80 ± 20 mm after one week of placebo TENS. The authors of seven studies concluded that TENS relieved pain but the findings of single small studies are unlikely to be correct.One study found clinically important improvements in Fibromyalgia Impact Questionnaire (FIQ) subscales for work performance, fatigue, stiffness, anxiety, and depression for TENS with exercise compared with exercise alone. One study found no additional improvements in FIQ scores when TENS was added to the first three weeks of a 12-week supervised exercise programme.No serious adverse events were reported in any of the studies although there were reports of TENS causing minor discomfort in a total of 3 participants.The quality of evidence was very low. We downgraded the GRADE rating mostly due to a lack of data; therefore, we have little confidence in the effect estimates where available.

Authors' conclusions: There was insufficient high-quality evidence to support or refute the use of TENS for fibromyalgia. We found a small number of inadequately powered studies with incomplete reporting of methodologies and treatment interventions.

PubMed Disclaimer

Conflict of interest statement

MIJ: none known. MIJ is a physiologist and authored a book "TENS. Research to Clinical Practice" in 2014. He is also involved in the professional training of healthcare practitioners about the use of TENS.

LSC: none known. LSC is a qualified physiotherapist and is involved in the professional training of physiotherapists about the use of TENS.

GPH: none known.

GJ: none known.

CAP: none known. CAP is a qualified physiotherapist and is involved in the professional training of physiotherapists about the use of TENS.

Figures

1
1
Study flow diagram.
2
2
Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
3
3
Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
See this image and copyright information in PMC

Comment in

References

References to studies included in this review

Carbonario 2013 {published data only}
    1. Carbonario F, Matsutani LA, Yuan SLK, Marques AP. Effectiveness of high‐frequency transcutaneous electrical nerve stimulation at tender points as adjuvant therapy for patients with fibromyalgia. European Journal of Physical and Rehabilitation Medicine 2013;49:197‐204. - PubMed
Dailey 2013 {published data only}
    1. Dailey D, Rakel B, Vance C, Lee J, Liebano R, Anand A, et al. Transcutaneous electrical nerve stimulation (TENS) reduces pain and improves function in people with fibromyalgia. Journal of Pain 2011;12:23.
    1. Dailey DL, Rakel BA, Vance CGT, Liebano RE, Amrit AS, Bush HM, et al. Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia. Pain 2013;154:2554‐62. - PMC - PubMed
    1. Vance C, Dailey D, Rakel B, Geasland K, Darghosian L, Alemo Munters L, et al. A novel method to obtain higher intensity TENS stimulation in clinical application. Journal of Pain 2015;1:S93.
da Silva 2008 {published data only}
    1. Silva TFG, Suda EY, Marçulo CA, Paes FHS, Pinheiro GT. Comparison of transcutaneous electrical nerve stimulation and hydrotherapy effects on pain, flexibility and quality of life in patients with fibromyalgia [Comparação dos efeitos da estimulação elétrica nervosa transcutânea e da hidroterapia na dor, flexibilidade e qualidade de vida de pacientes com fibromialgia]. Fisioterapia e Pesquisa 2008;15(2):118‐24.
Di Benedetto 1993 {published data only}
    1. Benedetto P, Iona LG, Zidarich V. Clinical evaluation of S‐adenosyl‐L‐methionine versus transcutaneous electrical nerve stimulation in primary fibromyalgia. Current Therapeutic Research 1993;53(2):222‐9.
Guo 2005 {published data only}
    1. Guo XJ, Jia J. Comparison of therapeutic effects of transcutaneous electrical nerve stimulation and electroacupuncture on fibromyalgia syndrome. Zhongguo Zhen Jiu 2003;23(11):653‐4.
    1. Guo XJ, Jia J. Comparison of therapeutic effects on fibromyalgia syndrome between dermal‐neurological electric stimulation and electric acupuncture. Chinese Journal of Clinical Rehabilitation 2005;9(46):171‐3.
Lauretti 2013 {published data only}
    1. Lauretti GR, Chubaci EF, Mattos AL. Efficacy of the use of two simultaneously TENS devices for fibromyalgia pain. Rheumatology International 2013;33:2117‐22. - PubMed
Lofgren 2009 {published data only}
    1. Lofgren M, Norrbrink C. Pain relief in women with fibromyalgia: a cross‐over study of superficial warmth stimulation and transcutaneous electrical nerve stimulation. Journal of Rehabilitation Medicine 2009;41(7):557‐62. - PubMed
Mutlu 2013 {published data only}
    1. Mutlu B, Paker N, Bugdayci D, Tekdos D, Kesiktas N. Efficacy of supervised exercise combined with transcutaneous electrical nerve stimulation in women with fibromyalgia: a prospective controlled study. Rheumatology International 2013;33:649‐55. - PubMed

References to studies excluded from this review

Arroyo 1993 {published data only}
    1. Arroyo JF, Cohen ML. Abnormal responses to electrocutaneous stimulation in fibromyalgia. Journal of Rheumatology 1993;20(11):1925‐31. - PubMed
Ido 2003 {published data only}
    1. Ido CS, Rothenbuhler R, Janz J, Loris L. Transcutaneous nerve electrostimulation of low frequency to tender points of the juvenile fibromyalgia patients [Eletroestimulação nervosa transcutanea de baixa frequencia nos tender points dos pacientes fibromialgicos juvenis]. Revista Fisioterapia Universidade Sao Paulo 2003;10(1):1‐6.
Kesiktas 2011 {published data only}
    1. Kesiktas N, Karagulle Z, Erdogan N, Yazicioglu K, Yilmaz H, Paker N. The efficacy of balneotherapy and physical modalities on the pulmonary system of patients with fibromyalgia. Journal of Back and Musculoskeletal Rehabilitation 2011;24(1):57‐65. - PubMed
Mutlu 2006 {published data only}
    1. Mutlu B, Paker N, Yylmaz E, Soy D. Comparison of therapeutic efficacy of transcutaneous electrical nerve stimulation (TENS) and exercise program in fibromyalgia syndrome: a prospective randomized study. Annals of the Rheumatic Diseases 2006;65:649‐55.
Simons 2006 {published data only}
    1. Simons DG, Dommerholt J. Myofascial pain syndromes ‐ trigger points. Journal of Musculoskeletal Pain 2006;14(1):59‐60.
Sunshine 1996 {published data only}
    1. Sunshine W, Field TM, Quintino O, Fierro K, Kuhn C, Burman I, et al. Fibromyalgia benefits from massage therapy and transcutaneous electrical stimulation. Journal of Clinical Rheumatology 1996;2(1):18‐22. - PubMed

References to ongoing studies

Noehren 2015 {unpublished data only}
    1. Noehren B, Dailey DL, Rakel BA, Vance CG, Zimmerman MB, Crofford LJ, et al. Effect of transcutaneous electrical nerve stimulation on pain, function, and quality of life in fibromyalgia: a double‐blind randomized clinical trial. Physical Therapy 2015;95(1):129‐40. - PMC - PubMed

Additional references

Aarskog 2007
    1. Aarskog R, Johnson MI, Demmink JH, Lofthus A, Iversen V, Lopes‐Martins R, et al. Is mechanical pain threshold after transcutaneous electrical nerve stimulation (TENS) increased locally and unilaterally? A randomized placebo controlled trial in healthy subjects. Physiotherapy Research International 2007;12(4):251‐63. - PubMed
AlBalawi 2013
    1. AlBalawi Z, McAlister FA, Thorlund K, Wong M, Wetterslev J. Random error in cardiovascular meta‐analyses: how common are false positive and false negative results?. International Journal Cardiology 2013;168(2):1102‐7. - PubMed
APTA 2001
    1. American Physical Therapy Association. Guide to physical therapist practice. Physical Therapy. 2nd Edition. Vol. 81, Alexandria (VA): American Physical Therapy Association, 2001. - PubMed
Bates 1980
    1. Bates JA, Nathan PW. Transcutaneous electrical nerve stimulation for chronic pain. Anaesthesia 1980;35(8):817‐22. - PubMed
Bennett 2007
    1. Bennett RM, Jones J, Turk DC, Russell IJ, Matallana L. An internet survey of 2,596 people with fibromyalgia. BMC Musculoskeletal Disorders 2007;8(1):27. - PMC - PubMed
Bennett 2011
    1. Bennett MI, Hughes N, Johnson MI. Methodological quality in randomised controlled trials of transcutaneous electric nerve stimulation for pain: low fidelity may explain negative findings. Pain 2011;156(2):1226‐32. - PubMed
Bidonde 2014
    1. Bidonde J, Busch AJ, Webber SC, Schachter CL, Danyliw A, Overend TJ, et al. Aquatic exercise training for fibromyalgia. Cochrane Database of Systematic Reviews 2014, Issue 10. [DOI: 10.1002/14651858.CD011336] - DOI - PMC - PubMed
Bidonde 2017
    1. Bidonde J, Busch AJ, Schachter CL, Overend TJ, Kim SY, Góes SM, et al. Aerobic exercise training for adults with fibromyalgia. Cochrane Database of Systematic Reviews 2017, Issue 6. [DOI: 10.1002/14651858.CD012700] - DOI - PMC - PubMed
Bjordal 2003
    1. Bjordal JM, Johnson MI, Ljunggreen AE. Transcutaneous electrical nerve stimulation (TENS) can reduce postoperative analgesic consumption. A meta‐analysis with assessment of optimal treatment parameters for postoperative pain. European Journal of Pain 2003;7:181‐8. - PubMed
Bjordal 2007
    1. Bjordal JM, Johnson MI, Lopes‐Martins RA, Bogen B, Chow R, Ljunggren AE. Short term efficacy of physical interventions in osteoarthritis knee pain: a systematic review and meta‐analysis of randomised placebo‐controlled trials. BMC Musculoskeletal Disorders 2007;22(8):8‐51. - PMC - PubMed
Boutron 2008
    1. Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P, CONSORT Group. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Annals Internal Medicine 2008;148(4):295‐309. - PubMed
Busch 2008
    1. Busch AJ, Schachter CL, Overend TJ, Peloso PM, Barber KA. Exercise for fibromyalgia: a systematic review. Journal of Rheumatology 2008;35(6):1130‐44. - PubMed
Busse 2015
    1. Busse JW, Bartlett SJ, Dougados M, Johnston BC, Guyatt GH, Kirwan JR, et al. Optimal strategies for reporting pain in clinical trials and systematic reviews: recommendations from an OMERACT 12 workshop. Journal of Rheumatology 2015; Vol. 42, issue 10:1962‐70. - PubMed
Catley 2015
    1. Catley MJ, Gibson W, Wand BM, Meads C, O'Connell NE. Transcutaneous Electrical Nerve Stimulation (TENS) for chronic pain ‐ an overview of Cochrane reviews. Cochrane Database of Systematic Reviews 2015, Issue 10. [DOI: 10.1002/14651858.CD011890] - DOI - PMC - PubMed
Charlton 2005
    1. Charlton J. Stimulation‐produced analgesia. In: Charlton J editor(s). Task Force on Professional Education. Washington (DC): IASP Press, 2005:93‐6.
Chen 2008
    1. Chen CC, Tabasam G, Johnson MI. Does the pulse frequency of transcutaneous electrical nerve stimulation (TENS) influence hypoalgesia? A systematic review of studies using experimental pain and healthy human participants. Physiotherapy 2008;94(1):11‐20.
Chen 2011
    1. Chen CC, Johnson MI. Differential frequency effects of strong non‐painful transcutaneous electrical nerve stimulation (TENS) on experimentally‐induced ischaemic pain in healthy human participants. Clinical Journal of Pain 2011;27(5):434‐41. - PubMed
Chesterton 2003
    1. Chesterton LS, Foster NE, Wright CC, Baxter GD, Barlas P. Effects of TENS frequency, intensity and stimulation site manipulation on pressure pain thresholds in healthy human subjects. Pain 2003;106(1‐2):73‐80. - PubMed
Claydon 2008a
    1. Claydon LS, Chesterton LS. Does transcutaneous electrical nerve stimulation (TENS) produce 'dose' responses? A review of systematic reviews on chronic pain. Physical Therapy Reviews 2008;13(6):450‐63.
Claydon 2008b
    1. Claydon LS, Chesterton LS, Barlas P, Sim J. Effects of simultaneous dual‐site TENS stimulation on experimental pain. European Journal of Pain 2008;12(6):696‐704. - PubMed
Claydon 2010
    1. Claydon LS, Chesterton LS, Johnson MI, Herbison GP, Bennett MI. Transcutaneous electrical nerve stimulation (TENS) for neuropathic pain in adults. Cochrane Database of Systematic Reviews 2010, Issue 10. [DOI: 10.1002/14651858.CD008756.pub2] - DOI
Claydon 2013
    1. Claydon LS, Chesteron LS, Barlas P, Sim J. Effects of alternating frequency TENS on experimental pain in healthy human participants: a randomised controlled trial. Clinical Journal of Pain 2013;29(6):533‐9. - PubMed
Dechartres 2013
    1. Dechartres A, Trinquart L, Boutron I, Ravaud P. Influence of trial sample size on treatment effect estimates: meta‐epidemiological study. BMJ 2013;346:f2304. - PMC - PubMed
DeSantana 2009
    1. DeSantana JM, Silva LF, Resende MA, Sluka KA. Transcutaneous electrical nerve stimulation at both high and low frequencies activates ventrolateral periaqueductal grey to decrease mechanical hyperalgesia in arthritic rats. Neuroscience 2009;163(4):1233‐41. - PMC - PubMed
Deyo 1990
    1. Deyo R, Walsh N, Schoenfeld L, Ramamurthy S. Can trials of physical treatments be blinded? The example of transcutaneous electrical nerve stimulation for chronic pain. American Journal of Physical Medicine and Rehabilitation 1990;69(1):6‐10. - PubMed
Dowswell 2009
    1. Dowswell T, Bedwell C, Lavender T, Neilson JP. Transcutaneous electrical nerve stimulation for pain relief in labour. Cochrane Database of Systematic Reviews 2009, Issue 2. [DOI: 10.1002/14651858.CD007214.pub2] - DOI - PMC - PubMed
Dworkin 2008
    1. Dworkin RH, Turk DC, Wyrwich KW, Beaton D, Cleeland CS, Farrar JT, et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. Journal of Pain 2008;9(2):105‐21. - PubMed
Francis 2011
    1. Francis RP, Johnson MI. The characteristics of acupuncture‐like transcutaneous electrical nerve stimulation (acupuncture‐like TENS): a literature review. Acupuncture & Electro‐Therapeutics Research 2011;36(3/4):231‐58. - PubMed
Furlan 2009
    1. Furlan AD, Pennick V, Bombardier C, Tulder M. Updated method guidelines for systematic reviews in the Cochrane Back Review Group. Spine 2009;34:1929‐41. - PubMed
Garrison 1996
    1. Garrison DW, Foreman RD. Effects of transcutaneous electrical nerve stimulation (TENS) on spontaneous and noxiously evoked dorsal horn activity in cats with transected spinal cords. Neuroscience Letters 1996;216(2):125‐8. - PubMed
Gibson 2017
    1. Gibson W, Wand BM, O'Connell NE. Transcutaneous electrical nerve stimulation (TENS) for neuropathic pain in adults. Cochrane Database of Systematic Reviews 2017, Issue 9. [DOI: 10.1002/14651858.CD011976] - DOI - PMC - PubMed
Gladwell 2015a
    1. Gladwell PW, Badlan K, Cramp F, Palmer S. Problems, solutions, and strategies reported by users of transcutaneous electrical nerve stimulation for chronic musculoskeletal pain: qualitative exploration using patient interviews. Physical Therapy 2015;96(7):1039‐48. - PubMed
Gladwell 2015b
    1. Gladwell PW, Badlan K, Cramp F, Palmer S. Direct and indirect benefits reported by users of transcutaneous electrical nerve stimulation for chronic musculoskeletal pain: qualitative exploration using patient interviews. Physical Therapy 2015;92(11):1518‐28. - PubMed
Goldenberg 1987
    1. Goldenberg DL. Fibromyalgia syndrome: an emerging but controversial condition. JAMA 1987;257:2782‐7. - PubMed
GRADEpro GDT 2015 [Computer program]
    1. GRADE Working Group, McMaster University. GRADEpro GDT. Hamilton (ON): GRADE Working Group, McMaster University, 2015.
Guyatt 2008
    1. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck‐Ytter Y, Alonso‐Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336(7650):924‐6. - PMC - PubMed
Guyatt 2013a
    1. Guyatt G, Oxman AD, Sultan S, Brozek J, Glasziou P, Alonso‐Coello P, et al. GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes. Journal of Clinical Epidemiology 2013;66:151‐7. - PubMed
Guyatt 2013b
    1. Guyatt GH, Oxman AD, Santesso N, Helfand M, Kunz R, Brozek J, et al. GRADE guidelines: 12. Preparing summary of findings tables ‐ binary outcomes. Journal of Clinical Epidemiology 2013;66:158‐72. - PubMed
Higgins 2011
    1. Higgins JPT, Green SE, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Houghton 2010
    1. Houghton P, Nussbaum E, Hoens A. Electrophysical agents ‐ contraindications and precautions: an evidence‐based approach to clinical decision making in physical therapy. Physiotherapy Canada 2010;62(5):1‐80. - PMC - PubMed
Hurlow 2012
    1. Hurlow A, Bennett MI, Robb KA, Johnson MI, Simpson KH, Oxberry SG. Transcutaneous electric nerve stimulation (TENS) for cancer pain in adults. Cochrane Database of Systematic Reviews 2012, Issue 3. [DOI: 10.1002/14651858.CD006276.pub3] - DOI - PMC - PubMed
Häuser 2012
    1. Häuser W, Jung E, Erbslöh‐Möller B, Gesmann M, Kühn‐Becker H, Petermann F, et al. The German fibromyalgia consumer reports ‐ a cross‐sectional survey. BMC Musculoskeletal Disorders 2012;13(1):74. - PMC - PubMed
Johnson 1992
    1. Johnson MI, Ashton CH, Thompson JW. Long‑term use of TENS at Newcastle Pain Relief Clinic. Journal of the Royal Society of Medicine 1992;85:267‐8. - PMC - PubMed
Johnson 2007
    1. Johnson M, Martinson M. Efficacy of electrical nerve stimulation for chronic musculoskeletal pain: a meta‐analysis of randomized controlled trials. Pain 2007;130(1‐2):157‐65. - PubMed
Johnson 2010
    1. Johnson MI, Walsh DM. Pain: continued uncertainty of TENS effectiveness for pain relief. Nature Reviews Rheumatology 2010;6(6):314‐6. - PubMed
Johnson 2011
    1. Johnson MI, Bjordal JM. Transcutaneous electrical nerve stimulation for the management of painful conditions: focus on neuropathic pain. Expert Review of Neurotherapeutics 2011;11(5):735‐53. - PubMed
Johnson 2014
    1. Johnson MI. Transcutaneous Electrical Nerve Stimulation (TENS). Research to Support Clinical Practice. 1st Edition. Oxford(UK): Oxford University Press, 2014.
Johnson 2015a
    1. Johnson MI, Paley CA, Howe TA, Sluka KA. Transcutaneous electrical nerve stimulation for acute pain. Cochrane Database of Systematic Reviews 2015, Issue 6. [DOI: 10.1002/14651858.CD006142.pub3] - DOI - PMC - PubMed
Johnson 2015b
    1. Johnson MI, Mulvey MR, Bagnall AM. Transcutaneous electrical nerve stimulation (TENS) for phantom pain and stump pain following amputation in adults. Cochrane Database of Systematic Reviews 2015, Issue 8. [DOI: 10.1002/14651858.CD007264.pub3] - DOI - PMC - PubMed
Kalra 2001
    1. Kalra A, Urban O, Sluka KA. Blockade of opioid receptors in rostral ventral medulla prevents anti‐hyperalgesia produced by transcutaneous electrical nerve stimulation (TENS). Journal of Pharmacological and Experimental Therapeutics 2001;298(1):257‐63. - PubMed
Khadilkar 2008
    1. Khadilkar A, Milne S, Brosseau L, Robinson V, Saginur M, Shea B. Transcutaneous electrical nerve stimulation (TENS) versus placebo for chronic low‐back pain. Cochrane Database of Systematic Reviews 2008, Issue 4. [DOI: 10.1002/14651858.CD003008.pub3] - DOI - PMC - PubMed
King 2001
    1. King EW, Sluka KA. The effect of varying frequency and intensity of transcutaneous electrical nerve stimulation on secondary mechanical hyperalgesia in an animal model of inflammation. Journal of Pain 2001;2:128‐33. - PubMed
Koroschetz 2011
    1. Koroschetz J, Rehm SE, Gockel U, Brosz M, Freynhagen R, Tolle TR, et al. Fibromyalgia and neuropathic pain ‐ differences and similarities. A comparison of 3057 patients with diabetic painful neuropathy and fibromyalgia. BMC Neurology 2011;11:55. - PMC - PubMed
L'Abbé 1987
    1. L'Abbé KA, Detsky AS, O'Rourke K. Meta‐analysis in clinical research. Annals of Internal Medicine 1987;107:224‐33. - PubMed
Leonard 2010
    1. Leonard G, Goffaux P, Marchand S. Deciphering the role of endogenous opioids in high‐frequency TENS using low and high doses of naloxone. Pain 2010;151(1):215‐9. - PubMed
Leonard 2011
    1. Leonard G, Cloutier C, Marchand S. Reduced analgesic effect of acupuncture‐like TENS but not conventional TENS in opioid‐treated patients. Journal of Pain 2011;12:213‐21. - PubMed
Liberati 2009
    1. Liberati A, Altman DG, Tezlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta‐analyses of studies that evaluate healthcare interventions: explanations and elaboration. BMJ 2009;339:b2700. - PMC - PubMed
Lunn 2014
    1. Lunn MP, Hughes RA, Wiffen PJ. Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia. Cochrane Database of Systematic Reviews 2014, Issue 1. [DOI: 10.1002/14651858.CD007115.pub3] - DOI - PMC - PubMed
Ma 2001
    1. Ma YT, Sluka KA. Reduction in inflammation‐induced sensitization of dorsal horn neurons by transcutaneous electrical nerve stimulation in anesthetized rats. Experimental Brain Research 2001;137(1):94‐102. - PubMed
Macfarlane 2017
    1. Macfarlane GJ, Kronisch C, Dean LE, Atzeni F, Häuser W, Fluß E, et al. EULAR revised recommendations for the management of fibromyalgia. Annals of the Rheumatic Diseases 2017;76:318‐28. - PubMed
Maeda 2007
    1. Maeda Y, Lisi TL, Vance CG, Sluka KA. Release of GABA and activation of GABA(a) in the spinal cord mediates the effects of TENS. Brain Research 2007;1136(1):43‐50. - PMC - PubMed
Melzack 1965
    1. Melzack R, Wall PD. Pain mechanisms: a new theory. Science 1965;150(3699):971‐9. - PubMed
Millan 2002
    1. Millan MJ. Descending control of pain. Progress in Neurobiology 2002;66(6):355‐474. - PubMed
Moore 1998
    1. Moore RA, Gavaghan D, Tramèr MR, Collins SL, McQuay HJ. Size is everything ‐ large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects. Pain 1998;78(3):209‐16. - PubMed
Moore 2008
    1. Moore RA, Barden J, Derry S, McQuay HJ. Managing potential publication bias. In: McQuay HJ, Kalso E, Moore RA editor(s). Systematic Reviews in Pain Research: Methodology Refined. Seattle (WA): IASP Press, 2008:15‐24.
Moore 2009
    1. Moore RA, Straube S, Wiffen PJ, Derry S, McQuay HJ. Pregabalin for acute and chronic pain in adults. Cochrane Database of Systematic Reviews 2009, Issue 3. [DOI: 10.1002/14651858.CD007076.pub2] - DOI - PMC - PubMed
Moore 2010a
    1. Moore RA, Eccleston C, Derry S, Wiffen P, Bell RF, Straube S, et al. "Evidence" in chronic pain ‐ establishing best practice in the reporting of systematic reviews. Pain 2010;150(3):386‐9. [DOI: 10.1016/j.pain.2010.05.011] - DOI - PubMed
Moore 2010b
    1. Moore RA, Straube S, Paine J, Phillips CJ, Derry S, McQuay HJ. Fibromyalgia: moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain. Pain 2010;149(2):360‐4. [DOI: 10.1016/j.pain.2010.02.039] - DOI - PubMed
Moore 2010c
    1. Moore RA, Moore OA, Derry S, Peloso PM, Gammaitoni AR, Wang H. Responder analysis for pain relief and numbers needed to treat in a meta‐analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice. Annals of the Rheumatic Diseases 2010;69(2):374‐9. [DOI: 10.1136/ard.2009.107805] - DOI - PMC - PubMed
Moore 2010d
    1. Moore RA, Smugar SS, Wang H, Peloso PM, Gammaitoni A. Numbers‐needed‐to‐treat analyses ‐ do timing, dropouts, and outcome matter? Pooled analysis of two randomized, placebo‐controlled chronic low back pain trials. Pain 2010;151(3):592‐7. [DOI: 10.1016/j.pain.2010.07.013] - DOI - PubMed
Moore 2011a
    1. Moore RA, Wiffen PJ, Derry S, McQuay HJ. Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database of Systematic Reviews 2011, Issue 3. [DOI: 10.1002/14651858.CD007938.pub3] - DOI - PMC - PubMed
Moore 2011b
    1. Moore RA, Straube S, Paine J, Derry S, McQuay HJ. Minimum efficacy criteria for comparisons between treatments using individual patient meta‐analysis of acute pain trials: examples of etoricoxib, paracetamol, ibuprofen, and ibuprofen/paracetamol combinations after third molar extraction. Pain 2011;152(5):982‐9. [DOI: 10.1016/j.pain.2010.11.030] - DOI - PubMed
Moore 2011c
    1. Moore RA, Mhuircheartaigh RJ, Derry S, McQuay HJ. Mean analgesic consumption is inappropriate for testing analgesic efficacy in post‐operative pain: analysis and alternative suggestion. European Journal of Anaesthesiology 2011;28(6):427‐32. [DOI: 10.1097/EJA.0b013e328343c569] - DOI - PubMed
Moore 2012a
    1. Moore RA, Derry S, Aldington D, Cole P, Wiffen PJ. Amitriptyline for neuropathic pain and fibromyalgia in adults. Cochrane Database of Systematic Reviews 2012, Issue 12. [DOI: 10.1002/14651858.CD008242.pub2] - DOI - PubMed
Moore 2012b
    1. Moore RA, Straube S, Eccleston C, Derry S, Aldington D, Wiffen P, et al. Estimate at your peril: imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses. Pain 2012;153(2):265‐8. [DOI: 10.1016/j.pain.2011.10.004] - DOI - PubMed
Moore 2013a
    1. Moore A, Derry S, Eccleston C, Kalso E. Expect analgesic failure: pursue analgesic success. BMJ 2013;346:f2690. - PubMed
Moore 2013b
    1. Moore RA, Straube S, Aldington D. Pain measures and cut‐offs ‐ 'no worse than mild pain' as a simple universal outcome. Anaesthesia 2013;68(4):400‐12. - PubMed
Moore 2013c
    1. Moore RA, Derry S, Wiffen PJ. Challenges in design and interpretation of chronic pain trials. British Journal of Anaesthesia 2013;111(1):38‐45. - PubMed
Moore 2014a
    1. Moore RA, Derry S, Taylor RS, Straube S, Phillips CJ. The costs and consequences of adequately managed chronic non‐cancer pain and chronic neuropathic pain. Pain Practice 2014;14(1):79‐94. - PubMed
Moore 2014b
    1. Moore RA, Cai N, Skljarevski V, Tölle TR. Duloxetine use in chronic painful conditions ‐ individual patient data responder analysis. European Journal of Pain 2014;18(1):67‐75. [DOI: 10.1002/j.1532-2149.2013.00341.x] - DOI - PMC - PubMed
Moran 2011
    1. Moran F, Leonard T, Hawthorne S, Hughes CM, McCrum‐Gardner E, Johnson MI, et al. Hypoalgesia in response to transcutaneous electrical nerve stimulation (TENS) depends on stimulation intensity. Journal of Pain 2011;12(8):929‐35. - PubMed
Nardone 1989
    1. Nardone A, Schieppati M. Influences of transcutaneous electrical stimulation of cutaneous and mixed nerves on subcortical and cortical somatosensory evoked potentials. Electroencephalography and Clinical Neurophysiology 1989;74(1):24‐35. - PubMed
Nüesch 2010
    1. Nüesch E, Trelle S, Reichenbach S, Rutjes AW, Tschannen B, Altman DG, et al. Small study effects in meta‐analyses of osteoarthritis trials: meta‐epidemiological study. BMJ 2010;341:c3515. - PMC - PubMed
O'Brien 2010
    1. O'Brien EM, Staud RM, Hassinger AD, McCulloch RC, Craggs JG, Atchison JW, et al. Patient‐centered perspective on treatment outcomes in chronic pain. Pain Medicine 2010;11(1):6‐15. [DOI: 10.1111/j.1526-4637.2009.00685.x] - DOI - PubMed
Pallett 2014
    1. Pallett EJ, Rentowl P, Johnson MI, Watson PJ. Implementation fidelity of self‐administered transcutaneous electrical nerve stimulation (TENS) in patients with chronic back pain: an observational study. Clinical Journal of Pain 2014;30:224‐31. - PubMed
PaPaS 2012
    1. PaPaS author and referee guidance. papas.cochrane.org/papas‐documents (accessed 22 January 2013).
Porfírio 2015
    1. Porfírio GJM, Martimbianco ALC, Brønfort G, Torloni MR, Riera R. Transcutaneous electrical nerve stimulation (TENS) for chronic neck pain. Cochrane Database of Systematic Reviews 2015, Issue 10. [DOI: 10.1002/14651858.CD011927] - DOI - PMC - PubMed
Queiroz 2013
    1. Queiroz LP. Worldwide epidemiology of fibromyalgia. Current Pain and Headache Reports 2013;17(8):356. - PubMed
Rakel 2010
    1. Rakel B, Cooper N, Adams HJ, Messer BR, Frey Law LA, Dannen DR, et al. A new transient sham TENS device allows for investigator blinding while delivering a true placebo treatment. Journal of Pain 2010;11(3):230‐8. - PMC - PubMed
RevMan 2014 [Computer program]
    1. Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Rutjes 2009
    1. Rutjes AW, Nuesch E, Sterchi R, Kalichman L, Hendriks E, Osiri M, et al. Transcutaneous electrostimulation for osteoarthritis of the knee. Cochrane Database of Systematic Reviews 2009, Issue 4. [DOI: 10.1002/14651858.CD002823.pub2] - DOI - PMC - PubMed
Santos 2013
    1. Santos CM, Fransischi JN, Lima‐Paiva P, Sluka KA, Resende MA. Effect of transcutaneous electrical stimulation on nociception and edema produced by peripheral serotonin. International Journal of Neuroscience 2013;123(7):507‐15. - PubMed
Sluka 1998
    1. Sluka KA, Bailey K, Bogush J, Olson R, Ricketts A. Treatment with either high or low frequency TENS reduces the secondary hyperalgesia observed after injection of kaolin and carrageenan into the knee joint. Pain 1998;77:97‐102. - PubMed
Sluka 1999
    1. Sluka KA, Deacon M, Stibal A, Stissel S, Terpstra A. Spinal blockade of opioid receptors prevents the analgesia produced by TENS in arthritic rats. Journal of Pharmacological and Experimental Therapeutics 1999;289(2):280‐6. - PubMed
Sluka 2000
    1. Sluka KA, Judge MA, McCoolley MM, Reveiz PM, Taylor BM. Low frequency TENS is less effective than high frequency TENS at reducing inflammation‐induced hyperalgesia in morphine‐tolerant rats. European Journal of Pain 2000;4:185‐93. - PubMed
Sluka 2006
    1. Sluka KA, Lisi TL, Westlund KN. Increased release of serotonin in the spinal cord during low, but not high, frequency transcutaneous electrical nerve stimulation in rats with joint inflammation. Archives of Physical Medicine and Rehabilitation 2006;87(8):1137‐40. - PMC - PubMed
Sluka 2013
    1. Sluka KA, Bjordal JM, Marchand S, Rakel BA. What makes transcutaneous electrical nerve stimulation work? Making sense of the mixed results in the clinical literature. Physical Therapy 2013;93(10):1397‐402. - PMC - PubMed
Somers 2009
    1. Somers DL, Clemente FR. Contralateral high or a combination of high‐and‐low frequency transcutaneous electrical nerve stimulation reduces mechanical allodynia and alters dorsal horn neurotransmitter content in neuropathic rats. Journal of Pain 2009;10(2):221‐9. - PubMed
Straube 2008
    1. Straube S, Derry S, McQuay HJ, Moore RA. Enriched enrolment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic review. British Journal of Clinical Pharmacology 2008;66(2):266‐75. [DOI: 10.1111/j.1365-2125.2008.03200.x] - DOI - PMC - PubMed
Straube 2010
    1. Straube S, Derry S, Moore RA, Paine J, McQuay HJ. Pregabalin in fibromyalgia ‐ responder analysis from individual patient data. BMC Musculoskeletal Disorders 2010;11:150. [DOI: 10.1186/1471-2474-11-150] - DOI - PMC - PubMed
Straube 2011
    1. Straube S, Moore RA, Paine J, Derry S, Phillips CJ, Hallier E, et al. Interference with work in fibromyalgia: effect of treatment with pregabalin and relation to pain response. BMC Musculoskeletal Disorders 2011;12:125. - PMC - PubMed
Sultan 2008
    1. Sultan A, Gaskell H, Derry S, Moore RA. Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials. BMC Neurology 2008;8:29. - PMC - PubMed
Vance 2007
    1. Vance CG, Radhakrishnan R, Skyba DA, Sluka KA. Transcutaneous electrical nerve stimulation at both high and low frequencies reduces primary hyperalgesia in rats with joint inflammation in a time‐dependent manner. Physical Therapy 2007;87(1):44‐51. - PubMed
Vos 2012
    1. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990‐2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2163‐96. - PMC - PubMed
Wiffen 2013
    1. Wiffen PJ, Derry S, Moore RA, Aldington D, Cole P, Rice ASC. Antiepileptic drugs for neuropathic pain and fibromyalgia ‐ an overview of Cochrane reviews. Cochrane Database of Systematic Reviews 2013, Issue 11. [DOI: 10.1002/14651858.CD010567.pub2] - DOI - PMC - PubMed
Winkelmann 2012
    1. Winkelmann A, Häuser W, Friedel E, Moog‐Egan M, Seeger D, Settan M, et al. Physiotherapy and physical therapies for fibromyalgia syndrome. Systematic review, meta‐analysis and guideline [Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften]. Schmerz (Berlin, Germany) 2012;26(3):276‐86. - PubMed
Winkelmann 2017
    1. Winkelmann A, Bork H, Brückle W, Dexl C, Heldmann P, Henningsen P, et al. Physiotherapy, occupational therapy and physical procedures for fibromyalgia syndrome [Physiotherapie, Ergotherapie und physikalische Verfahren beim Fibromyalgiesyndrom]. Schmerz (Berlin, Germany) 2017;31(3):255‐65. - PubMed
Winklemann 2011
    1. Winklemann A, Perrot S, Schaefer C, Ryan K, Chandran A, Sadosky A, et al. Impact of fibromyalgia severity on health economic costs: results from a European cross‐sectional study. Applied Health Economics and Health Policy 2011;9:125‐36. - PubMed
Wolfe 1990
    1. Wolfe F, Symthe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis and Rheumatism 1990;33:160‐72. - PubMed
Wolfe 2010
    1. Wolfe F, Clauw DJ, Fitzcharles MA, Coldenberg DL, Katz RS, Mease P, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care and Research 2010;62:600‐10. - PubMed
Wolfe 2013
    1. Wolfe F, Brahler E, Hinz A, Hauser W. Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population. Arthritis and Research Care 2013;645(5):777‐85. - PubMed
Wolfe 2014
    1. Wolfe F, Walitt BT, Hauser W. What is fibromyalgia, how is it diagnosed and what does it really mean?. Arthritis Care and Research 2014;66(7):969‐71. - PubMed

References to other published versions of this review

Nnoaham 2008
    1. Nnoaham KE, Kumbang J. Transcutaneous electrical nerve stimulation (TENS) for chronic pain. Cochrane Database of Systematic Reviews 2008, Issue 3. [DOI: 10.1002/14651858.CD003222.pub3] - DOI - PubMed